Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

LiDCO Group plc Receives FDA Clearance For Sale Non-Invasive Blood Pressure Monitor


Wednesday, 4 Sep 2013 02:00am EDT 

LiDCO Group plc announced that it has received clearance from the US Food and Drug Administration (FDA) for sales of the CNSystems' continuous non-invasive blood pressure monitoring (CNAPTM) module with the LiDCOrapidv2 monitor with Unity software. LiDCO's Unity software allows the connection to the LiDCOrapidv2 of modules to co-display CNSystems' continuous non-invasive blood pressure monitoring with Covidien's depth of anaesthesia parameter (BISTM). LiDCO believes there is growing demand for a multi-parameter monitor display which can reduce the number of single parameter monitors by the patient bedside. 

Company Quote

15.125
-0.25 -1.63%
22 Aug 2014